How Ph.D. was paid
$4.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Ryan J. Watts, Ph.D.President and Chief Executive Officer | $718,000 | $676,706 | $1,151,867 | $2,180,003 | $24,939 | $4,751,515 |
| Alexander O. Schuth, M.D.Chief Operating and Financial Officer and Secretary | $552,000 | $360,175 | $1,151,867 | $2,180,003 | $14,000 | $4,258,045 |
| Carole Ho, M.D.Chief Medical Officer and Head of Development | $483,000 | — | $1,151,867 | $2,180,003 | $14,000 | $3,828,870 |
What changed and why
- $4.8MCEO total compensation decreased to $4,751,515 in fiscal 2025 from $6,557,662 in fiscal 2024.
- $718KDr. Watts received a base salary of $718,000 for fiscal 2025.
- Stock and option awards for executives consisted of time-based RSUs and stock options.
- Dr. Ho resigned as Chief Medical Officer and Head of Development on November 14, 2025.
- 90.5%The 2025 advisory say-on-pay vote received approximately 90.5% support from stockholders.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.